IC
TTRX

IEQ Capital’s Turn Therapeutics TTRX Stock Holding History

IEQ Capital’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
+227,396
New +$1.06M 0.01% 884

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IEQ Capital's TTRX Position: Q2 2026 in Review

IEQ Capital opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 227,396 shares worth $1.66M. The stake represents 0.01% of the portfolio and ranks #884 among its holdings.

29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • IEQ Capital held 227,396 shares of Turn Therapeutics worth $1.66M as of Q2 2026.
  • Turn Therapeutics was a new IEQ Capital position in Q2 2026.
  • Turn Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #884 holding.
  • 29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.